| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2207136
Max Phase: Preclinical
Molecular Formula: C12H20N4O5
Molecular Weight: 300.31
Molecule Type: Protein
Associated Items:
Representations
Canonical SMILES: C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O
Standard InChI: InChI=1S/C12H20N4O5/c1-7(15-9(17)5-13)12(21)16-4-2-3-8(16)11(20)14-6-10(18)19/h7-8H,2-6,13H2,1H3,(H,14,20)(H,15,17)(H,18,19)/t7-,8-/m0/s1
Standard InChI Key: PRCWSSALMZBWJM-YUMQZZPRSA-N
Associated Targets(Human)
Peptidyl-glycine alpha-amidating monooxygenase 90 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 300.31 | Molecular Weight (Monoisotopic): 300.1434 | AlogP: -2.36 | #Rotatable Bonds: 6 |
| Polar Surface Area: 141.83 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.85 | CX Basic pKa: 7.84 | CX LogP: -5.32 | CX LogD: -5.44 |
| Aromatic Rings: 0 | Heavy Atoms: 21 | QED Weighted: 0.43 | Np Likeness Score: -0.85 |
References
| 1. Morris KM, Cao F, Onagi H, Altamore TM, Gamble AB, Easton CJ.. (2012) Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency., 22 (23): [PMID:23084901] [10.1016/j.bmcl.2012.10.004] |
Source
Source(1):